(redirected from Optic Neuritis Treatment Trial)
ONTTOptic Neuritis Treatment Trial (National Eye Institute)
ONTTOro-Neorectal Transit Time
References in periodicals archive ?
Experience of the Optic Neuritis Treatment Trial," Archives of Ophthalmology, vol.
Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.
[3] Optic Neuritis Study Group, "Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up," Archives of Neurology, vol.
Beck, "The optic neuritis treatment trial. Implications for clinical practice," Archives of Ophthalmology, vol.
The optic neuritis treatment trial. Arch Ophthalmol 1988;106(8):1051-3.
She serves as the Co-Director of the Coordinating Center for the Diabetes Control and Complications Trial and The Epidemiology of Diabetes Interventions and Complications and Principal Investigator of the Data Coordinating Center for the Optic Neuritis Treatment Trial, SCOUT, Uro-EDIC II, Biomarkers for Type 1 Diabetes Complications, Lipoproteins, Biomarkers-MUSC and Epigenetics.
The Optic neuritis treatment trial (ONTT) was a large well-designed study primarily investigating the natural course and management of optic neuritis.
[4.] The clinical profile of optic neuritis: ex perience of the optic neuritis treatment trial. Optic Neuritis Study Group.
The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results.
(21) In the Optic Neuritis Treatment Trial (ONTT), however, only one-third of patients presented with papillitis and swelling of the optic disc.
The prospective randomised and controlled Optic Neuritis Treatment Trial reported that oral prednisone alone had no benefit over placebo and may increase the future risk of repeat episodes of optic neuritis, while intravenous methylprednisolone 1 g daily for 3 days followed by 11 days of oral prednisone 1mg/ kg/day was associated with slightly faster visual recovery compared with placebo.
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003; 121: 944-949.